XML 16 R5.htm IDEA: XBRL DOCUMENT v3.25.3
Consolidated Condensed Statements of Cash Flows (Unaudited) - USD ($)
$ in Thousands
 9 Months Ended
Sep. 30, 2025
Sep. 30, 2024
Operating activities:    
Net loss $ (71,671) $ (71,340)
Adjustments to reconcile net loss to net cash used in operating activities:    
Share-based compensation 4,976 6,928
Stock issued for services 150 0
Depreciation 7,033 6,121
Debt related fees and amortization expense 4,831 4,892
Intangibles and other amortization expense 35 36
Accretion and other expenses of Series A preferred units 6,345 10,055
Loss (gain) on asset disposals (4) 3,644
Gain on debt extinguishment 0 (162)
Changes in operating assets and liabilities:    
Accounts receivable 517 557
Inventories 20,336 (1,618)
Prepaid expenses 179 1,566
Tax credit sale receivable 12,300 0
Other assets (676) (6,930)
Accounts payable (9,238) 3,481
Accrued interest expense and fees 19,484 20,873
Other liabilities 2,894 1,545
Net cash used in operating activities (2,509) (20,352)
Investing activities:    
Capital expenditures (9,441) (13,470)
Grant proceeds and other reimbursements received for capital expenditures 411 3,045
Net cash used in investing activities (9,030) (10,425)
Financing activities:    
Proceeds from borrowings 29,246 12,534
Repayments of borrowings (35,729) (4,841)
Payments on Series A preferred financing (2,200) 0
Lender debt renewal and waiver fee payments (495) (1,445)
Payments on finance leases (168) (170)
Proceeds from sales of common stock 25,487 21,680
Proceeds from exercise of stock options 257 36
Net cash provided by financing activities 16,398 27,794
Effect of exchange rate changes on cash, cash equivalents, and restricted cash (138) (4)
Net change in cash, cash equivalents, and restricted cash for period 4,721 (2,987)
Cash, cash equivalents, and restricted cash at beginning of period 3,831 6,280
Cash, cash equivalents and restricted cash at end of period 8,552 3,293
Supplemental disclosures of cash flow information, cash paid:    
Cash paid for interest 12,820 6,272
Income taxes paid 0 878
Supplemental disclosures of cash flow information, non-cash transactions:    
Settlement of Accounts Payable via issuance of Common Stock 45 0
Subordinated debt extension fees added to debt 680 680
Fair value of warrants issued to subordinated debt holders 584 916
Lender debt extension, waiver, and other fees added to debt 2,595 695
Cumulative capital expenditures in accounts payable and accruals $ 17,228 $ 10,060